Regeneron Pharmaceuticals reported $1.11B in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Agenus AGEN:US $ -44.56M 9.1M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Alimera Sciences ALIM:US $ -1.97M 2.17M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Astellas Pharma 4503:JP Y 33147M 46832M
AstraZeneca AZN:LN 44.27B 22.58B
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Bristol Myers Squibb BMY:US $ 2590M 37M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Johnson & Johnson JNJ:US $ 5840M 22M
Kyowa Hakko Kirin 4151:JP Y 21709M 4163M
Merk MRK:US $ 4927M 642M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NOVN:VX 2.23B 624M
Novartis NVS:US $ 2228M 624M
Ophthotech OPHT:US $ -49.75M 15.08M
Pfizer PFE:US $ 12102M 2229M
Puma Biotechnology PBYI:US $ 12M 12.77M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Teva Pharmaceutical TEVA:IT -949000000 236M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
United Therapeutics UTHR:US $ 201.8M 84.5M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
YTE INCY:US $ 254.43M 137.89M